◆ 会议时间：2021年11月9-12日
◆ 会议地点：美国 波士顿/Boston

◆ 会议简介：

2021年第14届阿尔茨海默病临床试验会议(CTAD)将于2021年11月9-12日在美国波士顿举行，会议的目的是汇集当今全球阿尔茨海默病治疗领域宣的领导者，讨论对下一代阿尔茨海默病治疗发展至关重要的新结果、候选疗法和方法论问题。来自世界各地的临床试验团队将报告他们在识别新的疾病生物标志物以及更敏感的临床评估工具方面所做的努力，以识别AD风险人群、预测进展，并评估新疗法的有效性。未经许可禁止复制摘录转载本站任何内容国际医学会议网(lingyuint.com)。

The 14th Clinical Trials on Alzheimer's Disease Conference will be held on November 9-12, 2021 in Boston, MA - USA

摘要：

Call for abstracts deadline: June 15, 2021

Late call for abstracts deadline: September 15, 2021

点此提交摘要>>>Submit Abstract>>>

Dear Colleague,

The Clinical Trials on Alzheimer's Disease conference (CTAD) is a meeting focused entirely on Alzheimer’s Disease Therapeutic Trials with key leaders in Alzheimer Disease research getting together and forming partnerships with the objective of speeding the development of effective treatments to fight the disease.

This year the 14th annual CTAD conference will be in Boston on November 9-12, 2021. Our new innovative format will combine an onsite meeting in Boston with on-demand scientific content on a digital platform.

CTAD’s prime mission is to inform and educate on the latest in AD therapeutic trials. Therefore, the entire cutting-edge scientific program will be fully available on demand on our digital platform for those who cannot attend in person in Boston for economic or travel reasons.

As such, onsite in Boston, the scientific program will feature the best presentations in the ballroom, leaving dedicated times for discussion and networking opportunities for delegates and partners.

Participants will be able to access additional content on demand on the digital platform.

CTAD 2021 combines the best of both options, participants will discover the latest updates in AD clinical research while enjoying the many networking opportunities CTAD has to offer in Boston.

Looking forward to seeing you in Boston!
 
On behalf of the Organizing Committee

Organizing Commitee

Jacques Touchon, MD, PhD, University of Montpellier, France

Paul Aisen, MD, Alzheimer's Therapeutic Research Institute (ATRI) at the University of Southern California (USC) at San Diego

Bruno Vellas, MD, PhD, University Hospital of Toulouse, France

Mike Weiner, MD, University of California San Francisco (UCSF), USA